About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

Luye Pharma Announces the Approval of Zepzelca® (Lurbinectedin for Injection) by China’s National Medical Products Administration for the ...

News

Shanghai, December 3, 2024 - Luye Pharma Group today announced that the innovative drug Zepzelca® (lurbinectedin for injection) has been approved for marketing by China’s National Medical Products Administration (NMPA) through the ...

December 03,2024

Luye Pharma’s Ruoxinlin and Other Drugs Included on China’s 2024 National Reimbursement Drug List

Shanghai, November 28, 2024 – Luye Pharma Group today announced that several of its innovative products (including new indications) have been included in the National Reimbursement Drug List for Basic Medical Insurance, Work-Related ...

November 28,2024

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company